PROFUSE TECHNOLOGY LTD
General Data
Reg Number
516412665
Sector
Biomed
Established
2021
No. of Employees
15
Stage
R&D
Additional Funding
0
Technology
ProFuse's technology is based on a six years groundbreaking study by the Weizmann Institute of Science led by Professor Eldad Tzahor - a world-renowned expert in the field of embryonic development and cell regeneration, Dr. Ori Avinoam who specializes in intercellular fusion and tissue formation, and Dr. Tamar Eigler who specializes in stem cell biology muscle. The company specializes on muscle cultivation. ProFuse’s products for the cultivated meat sector include cell lines and media supplements which reduces production time, increase yield and enhances the production capacity of cultured meat by accelerating muscle fiber growth. Life Science customers use ProFuse media supplements and proprietary cell line that were customized with unique reporters to discover drugs for treating muscle atrophy. The solutions and additives offered are based on the activation (patent pending) of a biochemical signaling pathway which acts at two distinct phases of myogenesis, by accelerating differentiation and enhancing fusion of myoblasts.
Targeted Customers
Cell culture media producers, cultured meat A-Z vendors
Management personnel
Guy Michrowski - CEO & Co-Founder
Tamar Eigler-Hirsh - CTO & Co-Founder
Winning details
Route name
Winning year
R&D Program
R&D Program
2023